← Human Trials & Peer-Reviewed Studies

Exposure to electronic nicotine delivery systems (ENDS) visual imagery increases smoking urge and desire.

Plain-language guide to PMID 26618797 (2016): randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID
26618797
Journal
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
Year
2016
Study type
Randomized Controlled Trial
Authors
King AC et al. (6 authors)
DOI
10.1037/adb0000123

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.

As use of ENDS resembles traditional smoking in both hand-to-mouth movements and inhalation and exhalation behaviors, the researchers determined whether exposure to e-cigarette use via video exposure would act as a cue to elicit urge and desire for a combustible cigarette.

Pre- and postcue exposure assessments were conducted in a controlled laboratory setting without other smoking or vaping cues present or behaviors allowed.

Who Took Part

By PubMed's age tags, the people studied were young adults and adults, both men and women.

Young adult smokers (mean age of 26.3 ± 4.1 years) were randomized to view a brief video montage of advertisements depicting either e-cigarette vaping (n = 38) or bottled water drinking (n = 40).

How the Study Was Run

The design is described as randomized.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

Pre- and postcue exposure assessments were conducted in a controlled laboratory setting without other smoking or vaping cues present or behaviors allowed.

The subject headings attached to it are Craving, Cues, Electronic Nicotine Delivery Systems and Tobacco Products.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2016 (Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.